Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 24, 2020

Primary Completion Date

July 17, 2021

Study Completion Date

September 17, 2021

Conditions
HypoxemiaPneumonia, ViralCoronavirus Infection
Interventions
DRUG

Nitric Oxide-Sessions

Nitric Oxide will be delivered at 200 ppm in 2 daily sessions (morning, evening; 9-12 hours apart) for 14 days. Each session will last 30 minutes, for a total of 60 minutes/day for each patient. A tank of NO gas will be connected to the inspiratory limb of the circuit, and the flow will be adjusted to deliver a target concentration of 200 ppm NO. Commercially available tanks will be used to provide the gas. The desired mixture of air, oxygen (O2), and NO will be titrated with the respective flowmeter to reach a concentration of 200 ppm at the inspiratory limb with the desired Fraction of inspired oxygen (FiO2).

DRUG

Nitric Oxide-Continuous and Sessions

"Nitric Oxide will be delivered at 200 ppm in 2 daily sessions (morning, evening; 9-12 hours apart) for 14 days. Each session will last 30 minutes, for a total of 60 minutes/day for each patient. A tank of NO gas will be connected to the inspiratory limb of the circuit, and the flow will be adjusted to deliver a target concentration of 200 ppm NO. Commercially available tanks will be used to provide the gas. The desired mixture of air, oxygen (O2), and NO will be titrated with the respective flowmeter to reach a concentration of 200 ppm at the inspiratory limb with the desired Fraction of inspired oxygen (FiO2).~The subjects assigned to the group NO High Concentration + Continuous Low Concentration will receive in adjunction a continuous dose of NO at 20 ppm."

Trial Locations (1)

634012

Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk

All Listed Sponsors
collaborator

Siberian State Medical University

OTHER

lead

Tomsk National Research Medical Center of the Russian Academy of Sciences

OTHER

NCT04476992 - Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement | Biotech Hunter | Biotech Hunter